405 – Efficacy and Safety Results 48 Weeks After Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) Vs Continued Tdf Treatment in Virologically-Suppressed Patients with Chronic Hepatitis B (CHB)
作者
Pietro Lampertico,Marı́a Buti,Scott Fung,Sang Hoon Ahn,Wan‐Long Chuang,Won Young Tak,Alnoor Ramji,Chi-Yi Chen,Edward Tam,Ho Bae,Xiaoli Ma,John F. Flaherty,Anuj Gaggar,Audrey Lau,Becket Feierbach,George Y. Wu,Vithika Suri,Mani Subramanian,Huy N. Trinh,Seung-Kew Yoon